Advanced Interventional Cardiology

 Beyond the Silhouette: Intravascular Imaging (IVO)

Standard angiography only provides a 2D "shadow" of the artery. Next-generation PCI relies on "seeing from the inside out."

  • IVUS (Intravascular Ultrasound): Uses sound waves to see the plaque's depth and the arterial wall. It is the gold standard for ensuring a stent is properly "apposed" (snug against the wall).

  • OCT (Optical Coherence Tomography): Uses light to provide near-microscopic resolution. It’s the "high-definition" camera of the heart, perfect for identifying unstable plaques or tiny tears (dissections).

Physiology-Guided Decision Making: FFR and iFR

Just because a blockage looks bad doesn't mean it's restricting blood flow. Advanced PCI uses "Physiologic Assessment" to prevent unnecessary stenting.

  • FFR (Fractional Flow Reserve): Uses a pressure wire to measure the pressure drop across a lesion.

  • iFR (Instant Wave-Free Ratio): A newer, faster technique that doesn't require the patient to take medication (adenosine) to stress the heart.

  • The Goal: If the $FFR > 0.80$, the blockage is often better treated with medication than a stent.

 Dealing with "The Rock": Advanced Lesion Preparation

One of the biggest hurdles in next-gen PCI is calcification. You can't put a soft stent in a hard, "rock-like" artery.

  • Intravascular Lithotripsy (IVL): Often called "Shockwave" therapy. It uses sonic pressure waves to crack calcium without damaging the soft tissue of the artery.

  • Orbital/Rotational Atherectomy: Using a tiny, diamond-tipped drill to "sand down" calcium.

 Robotic-Assisted PCI

The future of the "cath lab" involves the physician sitting at a cockpit rather than standing at the bedside.

  • Precision: Robots can move wires and stents in $1 \text{ mm}$ increments—far more precise than the human hand.

  • Safety: Reduces radiation exposure for the medical team and allows for better ergonomic control during long, complex cases.

 Summary: The "Triple Threat" of Modern PCI

To wrap up your post, emphasize that the best clinical outcomes now come from combining:

  1. Imaging (Where to put the stent?)

  2. Physiology (Should we put a stent at all?)

  3. Advanced Prep (How do we make the stent last?)

Comparison of PCI Approaches

FeatureTraditional PCINext-Generation PCI
GuidanceVisual (Angiogram)Imaging (IVUS/OCT)
Criteria% StenosisPhysiology (FFR/iFR)
Calcium PrepHigh-pressure balloonsLithotripsy / Atherectomy
PrecisionManual placementRobotic / Image-integrated
To know more, visit: https://www.cardiology.scientexconference.com/sessions/Interventional-Cardiology

Comments

Post a Comment

Popular posts from this blog

Image
  Ventricular Assist Device – Miniature The treatment of individuals with severe heart failure has been transformed by the development of a ventricular assist device (VAD). When a donor heart cannot be identified, the VAD, which was initially designed as a bridge to transplantation , has been proved to extend life and improve quality of life. Older models needed patients to ambulate with hefty , huge external batteries and control devices and required the implantation of a big pump. Yet in the upcoming years, a number of ground-breaking advancements in device size , battery life, and even wireless charging technologies may render these devices physically undetectable and possibly reduce patient vulnerability to infections. The rates of haemolysis, thrombosis, and secondary aortic valve insufficiency have also been constrained by numerous mechanical improvements and newer operating paradigms. Cardiac Decellularization and Engineered Heart Tissue Promising new direction...
Read more
Image
Myocardial infarction events involving morality, incredibly high temperatures, and minute particles.  Myocardial infarction (MI) morbidity has been connected to extreme temperature events (ETEs), such as heat wave and cold spell, but their effects on MI mortality are less well understood. Although ambient fine particulate matter (PM2.5) and severe temperatures may work in concert to increase cardiovascular mortality , it is still unclear whether or how ETEs and PM2.5 interact to cause MI deaths.METHODS: To examine the relationship between exposure to ETEs and PM2.5 and MI mortality and assess their interacting effects, a time-stratified case-crossover study of 202 678 MI deaths in Jiangsu province, China, from 2015 to 2020 was conducted. Twelve ETE definitions were created using a variety of temperature thresholds and durations based on the perceived ambient temperature. In order to estimate daily ETEs and PM2.5exposures , values were taken from validated grid datasets at reside...
Read more

New Drug Nearly Eradicates “Stealth” Cholesterol (Lp(a)) – A Game‑Changer in Heart Disease Prevention

Image
A recent clinical trial reported in the New England Journal of Medicine and showcased at the American College of Cardiology revealed that lepodisiran—an experimental RNA-targeting drug—can reduce lipoprotein(a) [Lp(a)] by nearly 100% after a single dose, with sustained effects over a year 🔍 What You Need to Know Lp(a) is a genetically determined, stealth cholesterol that significantly raises the risk of heart attacks and strokes yet is not addressed by diet or standard statins. The Phase 2 trial, involving 320 participants across 10 countries, showed almost total Lp(a) suppression at 6 months, maintained at 1 year. Reported side effects were mild, primarily limited to injection-site reactions. No serious safety issues were found.                      🌍 Why This Matters This breakthrough could pave the way for targeted Lp(a) therapies—potentially reducing cardiovascular risk in over 1.4 billion people globally with elevated levels....
Read more